DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Ageno W, Mantovani LG, Haas S. et al.
Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
Lancet Haematol 2016;
3 (01) e12-e21
We do not assume any responsibility for the contents of the web pages of other providers.